News
Unichem has obtained tentative approval from the Food and Drug Administration for sitagliptin tablets in dosage strengths of 25 mg, 50 mg, and 100 mg The medication is a generic of Merck Sharpe ...
Unichem Laboratories is recalling 96,876 bottles of Bisoprolol Fumarate tablets used for the treatment of hypertension from the US market. Unichem Pharmaceuticals USA Inc is recalling the tablets ...
NEW DELHI: Drug firm Unichem Laboratories has received approval from the US health regulator for its Montelukast Sodium tablets used in prevention and chronic treatment of asthma. "The company has ...
Share of Unichem Laboratories rose 4 per cent to hit an intraday high of Rs 340.80 on BSE after the company announced that it has received tentative approval for ANDA of Sitagliptin Tablets USP ...
Unichem Laboratories Limited has received ANDA approval for its Quetiapine Extended-Release Tablets USP, 50 mg, 150 mg, 200 mg, 300 mg, and 400 mg from the United States Food and Drug ...
Unichem Laboratories has received ANDA approval for its Quetiapine Extended-Release Tablets USP, 50 mg, 150 mg, 200 mg, 300 mg, and 400 mg from the United States Food and Drug Administration ...
Ipca, which makes paracetamol tablets under the brand name Pacimol, is also launching an open offer to Unichem's shareholders to buy an additional 26% stake for 8.05 billion rupees, it said in a ...
Ipca, which makes paracetamol tablets under the brand name Pacimol, will also launch an open offer to Unichem's shareholders to buy an additional 26% stake for 8.05 billion rupees, according to a ...
Hosted on MSN14d
Unichem Laboratories gets EIR from USFDA for Pithampur facilityUnichem Laboratories is engaged in manufacturing of pharmaceutical products. The company's consolidated net profit tanked 21% to Rs 57.85 crore in Q3 FY25, compared with Rs 73.22 crore in Q3 FY24.
The European Commission fined Servier 331 million euros ($354 million) in 2014 - and also fined generic drugmakers Teva (TEVA.TA), opens new tab, Unichem and its subsidiary Niche, Matrix which is ...
High Street retailer Boots has said it is to merge with rival Alliance UniChem in a deal worth £7bn ($12bn). The merger will create one of Europe's largest drugs, beauty and healthcare groups with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results